1. Home
  2. JNJ

JNJ

Johnson & Johnson

Logo Johnson & Johnson

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Founded: 1886 Country:
United States
United States
Employees: N/A City: NEW BRUNSWICK
Market Cap: 356.4B IPO Year: 1944
Target Price: $166.21 AVG Volume (30 days): 7.5M
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield: 3.33% Dividend Payout Frequency: Quarterly
EPS: 13.72 EPS Growth: 103.86
52 Week Low/High: $144.95 - $175.97 Next Earning Date: 04-16-2024
Revenue: $85,159,000,000 Revenue Growth: 6.46%
Revenue Growth (this year): 4.88% Revenue Growth (next year): 2.71%

Share on Social Networks:

Stock Insider Trading Activity of Johnson & Johnson (JNJ)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Broadhurst Vanessa JNJ EVP, Global Corp Affairs Mar 13 '24 Sell $162.16 8,891 $1,441,764.56 15,043 SEC Form 4

Similar to JNJ Stocks: